Tentative Settlement Reached in Risperdal Marketing Case, J&J Says
Johnson & Johnson (J&J) has a reached an agreement in principle with federal prosecutors to settle off-label marketing matters pending in three states, J&J said in an SEC filing Thursday.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.